Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs.

Turner, Hugo C; French, Michael D; Montresor, Antonio; King, Charles H; Rollinson, David; Toor, Jaspreet

Turner, Hugo C; French, Michael D; Montresor, Antonio; King, Charles H; Rollinson, David; Toor, Jaspreet.

Afiliación

Turner HC; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, St Mary's Campus, Imperial College London, London, W2 1PG, UK.
French MD; Oxford University Clinical Research Unit, Wellcome Africa Asia Programme, Ho Chi Minh City, Vietnam.
Montresor A; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
King CH; RTI International, Washington, 20005, USA.
Rollinson D; Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
Toor J; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, USA.

Wellcome Open Res ; 5: 45, 2020.

Article en En | MEDLINE | ID: mdl-32587899

Palabras clave

Cost per DALY averted; Cost-benefit; Cost-effectiveness; Economic evaluations; MDA; NTDs; Preventive chemotherapy; Schistosomiasis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Wellcome Open Res Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google